SYSTEMS AND METHODS FOR DISTRIBUTING CONTINUOUS GLUCOSE DATA

• US 20160232322A1
• Filed: 02/09/2016
• Published: 08/11/2016
• Est. Priority Date: 02/10/2015
• Status: Abandoned Application

• Current Assignee: DexCom Incorporated
• Original Assignee: DexCom Incorporated
• Inventors: Morris, Gary A., Mensinger, Michael Robert, Cabrera, Esteban Jr., Cohen, Eric, Heintzman, Nathaniel David, Kamath, Apurv Ullas, Pal, Andrew Attila, Reihman, Eli, Valdes, Jorge
• Application Number:
  US15/019,807
• Publication Number:
  US 20160232322A1
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: A61B 5/0002 Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network A61B5/07 takes precedence; transmission systems for measured values G08C; transmission H04B; transmission of digital information H04L; wireless communication networks H04W
• CPC Class Codes: A61B 5/0004 characterised by the type of physiological signal transmitted
• CPC Class Codes: A61B 5/0022 Monitoring a patient using a global network, e.g. telephone networks, internet
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/7275 Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
• CPC Class Codes: A61B 5/742 using visual displays A61B5/339 takes precedence
• CPC Class Codes: G06F 21/602 Providing cryptographic facilities or services
• CPC Class Codes: G06F 21/62 Protecting access to data via a platform, e.g. using keys or access control rules
• CPC Class Codes: G06F 21/6245 Protecting personal data, e.g. for financial or medical purposes
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment

Abstract

The present disclosure relates to systems, devices and methods for receiving biosensor data acquired by a medical device, e.g., relating to glucose concentration values, and controlling the access and distribution of that data. In some embodiments, systems and methods are disclosed for monitoring glucose levels, displaying data relating to glucose values and metabolic health information, and controlling distribution of glucose data between applications executing on a computer, such as a smart phone. In some embodiments, systems and methods are disclosed for controlling access to medical data such as continuously monitored glucose levels, synchronizing health data relating to glucose levels between multiple applications executing on a computer, and/or encrypting data.

Claims

1. A method for monitoring glucose values, comprising:

receiving, at a first application operable on a mobile computing device, health data including a glucose measurement and associated timestamp transmitted over a wireless connection;

determining, by the first application, that a time duration between a current time and the timestamp meets a predetermined amount of delay; and

providing, by the first application, the glucose measurement to a second application operable on the mobile computing device only after the predetermined amount of delay.

2. The method of claim 1, wherein the first application includes a medical device software application that configures the mobile computing device to receive and process glucose data including the glucose measurement provided by a continuous glucose monitoring sensor device, and wherein the second application includes a third-party software application.

3. The method of claim 2, wherein the third-party software application is configured to provide at least some capabilities different than that of the first application including processing ancillary data and integrating the ancillary data with the glucose data, wherein the ancillary data includes one or more of insulin data, meal data, or exercise data.

4. The method of claim 2, wherein the third-party software application is not an approved medical device software application approved by a governmental regulatory institution authorized to regulate medical device technologies.

5. The method of claim 1, wherein the received health data includes a plurality of continuously generated glucose measurements and associated timestamps for each glucose measurement;

and the method comprises;

delaying each of the plurality of continuously generated glucose measurements for the predetermined amount of time; and

providing each of the plurality of continuously generated glucose measurements to the second application after the delaying.

6. The method of claim 1, wherein the glucose measurement is provided to the second application, after the predetermined amount of time, in response to the second application being executed by the mobile computing device.

7. The method of claim 1, wherein the delay is between five minutes and three hours.

8. The method of claim 1, further comprising:

obtaining metabolic health information affecting glucose levels; and

displaying, using the first application, the glucose measurement concurrently with the metabolic health information, wherein the metabolic health information is obtained by the first application from the second application.

9. The method of claim 8, wherein:

the metabolic health information indicates an amount of activity determined using motion data produced by an accelerometer of the mobile computing device;

or

the metabolic health information comprises at least one of meal intake, exercise, or insulin injection.

10. The method of claim 5, further comprising:

creating from the received health data, by the first application, a set of data relating to the continuously generated glucose measurements;

dividing, by the first application, the set of data by generating a first set of data and a second set of data according to a predetermined criteria;

restricting access to the second set of data to the second application; and

providing the first set of data to the second application.

11. The method of claim 10, wherein the dividing the set of data into the first set of data includes averaging the continuously generated glucose measurements over a predetermined interval to produce glucose average values to be in the first set of data.

12. The method of claim 10, wherein the dividing the set of data into the first set of data includes generating generalized indications of the continuously generated glucose measurements over a predetermined interval to be in the first set of data, wherein a generalized indication is representative of the continuously generated glucose measurements being in one of a predefined low range, a predefined normal range, and a predefined high range.

13. The method of claim 1, further comprising:

encrypting the glucose measurement prior to the providing the glucose measurement to the second application;

transmitting an instruction for the second application to provide the encrypted measurement to a third application operable on the mobile computing device; and

providing a key to decrypt the encrypted measurement to the third application.

14. The method of claim 13, wherein the providing includes providing the key to the second application with a communication for the second application to provide the key to the third application.

15. The method of claim 1, wherein the first application is configured to process glucose data associated with a continuous glucose sensor device;

and the method further comprising;

receiving from a third-party application, at the first application, one or more single glucose measurements acquired from a single-measurement glucose sensor device;

analyzing, by the first application, metadata corresponding to the one or more single glucose measurements; and

authenticating, by the first application, the one or more single glucose measurements as calibration data for the continuous analyte sensor device.

16. A system for monitoring glucose values, comprising:

a sensor configured to obtain a glucose measurement of an amount of glucose;

a wireless transmitter to transmit the glucose measurement and a timestamp associated with the glucose measurement; and

a mobile computing device, comprising;

a wireless receiver configured to receive the glucose measurement,

a memory to store data including the received glucose measurement,

a processor to process the data, and

a first software application including instructions stored in the memory which, when executed by the processor, determines when a time duration between a current time and the timestamp meets a predetermined amount of delay, and upon determination the time duration meets the predetermined amount of delay, provides the glucose measurement to a second software application on the mobile computing device,

wherein the second software application is operable to receive the glucose measurement when provided by the first software application after the predetermined amount of delay.

17. The system of claim 16, wherein the first software application includes a medical device software application that configures the mobile computing device to receive and process the glucose measurement received from the sensor, and wherein the second software application includes a third-party software application.

18. The system of claim 17, wherein the third-party software application is configured to provide at least some capabilities different than that of the first software application including processing ancillary data and integrating the ancillary data with the glucose measurement, wherein the ancillary data includes one or more of insulin data, meal data, or exercise data.

19. The system of claim 17, wherein the third-party software application is not an approved medical device software application approved by a governmental regulatory institution authorized to regulate medical device technologies.

20. The system of claim 16, wherein the glucose measurement is provided to the second software application, after the delay, in response to the second software application being executed.

21. The system of claim 16, wherein the delay is between five minutes and three hours.

22. The system of claim 16, wherein:

the wireless receiver of the mobile computing device is configured to receive a plurality of continuously generated glucose measurements and a timestamp associated with each continuously generated glucose measurement;

the memory of the mobile computing device is configured to store the plurality of continuously generated glucose measurements; and

the first software application includes instructions, which when executed by the processor, causes the mobile computing device to;

delay each of the plurality of continuously generated glucose measurements for the predetermined amount of time, and

provide each of the plurality of continuously generated glucose measurements to the second software application after the delay.

23. The system of claim 22, wherein the first software application includes instructions, which when executed by the processor causes the mobile computing device to:

create a set of data relating to the continuously generated glucose measurements;

divide the set of data by generating a first set of data and a second set of data according to a predetermined criteria;

restrict access to the second set of data to the second software application; and

provide the first set of data to the second software application.

24. The system of claim 23, wherein the generating the first set of data includes averaging the continuously generated glucose measurements over a predetermined interval to produce glucose average values to be in the first set of data.

25. The system of claim 23, wherein the generating the first set of data includes generating generalized indications of the continuously generated glucose measurements over a predetermined interval to be in the first set of data, wherein a generalized indication is representative of the continuously generated glucose measurements being in one of a predefined low range, a predefined normal range, and a predefined high range

26. The system of claim 16, wherein the first software application includes instructions, which when executed by the processor causes the mobile computing device to:

encrypt the glucose measurement prior to providing the glucose measurement to the second software application;

transmit an instruction for the second software application to provide the encrypted measurement from the second software application to a third software application operable on the mobile computing device; and

provide a key to the third software application to decrypt the encrypted measurement.

27. A medical device software application on a computer-readable medium of a mobile computing device, the medical device software application for managing glucose data received from a glucose sensor, and comprising instructions which, when executed by a processor of the mobile computing device, causes the mobile computing device to:

receive one or more glucose measurements generated by the glucose sensor, wherein the one or more glucose measurements include an associated timestamp;

assign the received one or more glucose measurements as retrospective glucose data or actionable glucose data based on a predetermined amount of time difference between the timestamp and a current time; and

provide the retrospective glucose data to a third-party software application operable on the mobile computing device.

28. The medical device software application of claim 27, wherein the third-party software application is not an approved medical device software application approved by a governmental regulatory institution authorized to regulate medical device technologies.

29. The medical device software application of claim 27, wherein the third-party software application is configured to provide at least some capabilities different than that of the medical device software application including processing ancillary data and integrating the ancillary data with the retrospective glucose data, wherein the ancillary data includes one or more of insulin data, meal data, or exercise data.

30. The medical device software application of claim 27, wherein the medical device software application includes instructions, which when executed by the processor, causes the mobile computing device to:

create a set of data relating to the one or more glucose measurements;

divide the set of data by generating a first set of data and a second set of data according to a predetermined criteria;

restrict access to the first set of data to the third-party software application; and

provide the second set of data to the third-party software application.

31. The medical device software application of claim 27, wherein the medical device software application includes instructions, which when executed by the processor, causes the mobile computing device to:

encrypt the received one or more glucose measurements or the assigned retrospective glucose data prior to providing the retrospective glucose data to the third-party software application;

transmit an instruction for the third-party software application to provide the encrypted retrospective glucose data to a second third-party software application operable on the mobile computing device; and

provide a key to the second third-party software application to decrypt the encrypted retrospective glucose data.